Tirzepatide in MetALD

Clinical trial NCT07046819 · RECRUITING

Trial details

NCT number: NCT07046819
Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metabolic Alcohol-associated Liver Disease Alcohol Use Disorder

Start date: 2026-06-11
Primary completion: 2027-07-30
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.